Febrile Neutropenia
📧 Sign up to get email alerts when something new happens for Febrile Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
A planned clinical trial to evaluate plasma host-microbe proteomics as a predictor of complications in patients with high-risk febrile neutr…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
This completed clinical trial explored factors distinguishing the risk of severe infection in patients with febrile neutropenia after chemot…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Comparative Evaluation of Pharmacokinetics and Immunogenicity. [Phase 1]
Phase 1 trial by Kashiv BioSciences evaluating pharmacokinetics and immunogenicity of an investigational product in febrile neutropenia. The…
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia [Phase 4]
This Phase 4 trial investigated early versus late stopping of antibiotics in children with cancer who have high-risk febrile neutropenia; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. [Phase 3]
Phase 3 trial comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate plus ciprofloxacin for outpatient management of chemoth…
-
EMA approval · 2026-03-18EMA Authorised: Cegfila (previously Pegfilgrastim Mundipharma) (pegfilgrastim) — Mundipharma Corporation (Ireland) Limited
The EMA authorised the pegfilgrastim product Cegfila (Mundipharma) for marketing in the European Union.
-
EMA approval · 2026-02-24EMA Authorised: Vivlipeg (pegfilgrastim) — Biosimilar Collaborations Ireland Limited
The EMA authorised Vivlipeg, a biosimilar pegfilgrastim. The product is indicated for neutropenia and related febrile neutropenia in cancer …
-
EMA approval · 2026-02-19EMA Authorised: Fulphila (pegfilgrastim) — Biosimilar Collaborations Ireland Limited
EMA authorised Fulphila, a pegfilgrastim biosimilar by Biosimilar Collaborations Ireland Limited. The approval covers its use to reduce the …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients [NA]
This clinical trial update describes ongoing research on optimal antibiotic duration and outcomes in high-risk febrile neutropenia patients,…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia [NA]
This registry entry describes a planned pediatric oncology trial to assess a telemonitoring device for children at risk of chemotherapy-indu…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule [NA]
Trial update noting the termination status of the DIStinguishing Children at Low Risk of Severe infection in Case of Febrile Neutropenia-7 t…
-
EMA approval · 2025-12-08EMA Authorised: Neulasta (pegfilgrastim) — Amgen Europe B.V.
EMA authorised Neulasta (pegfilgrastim) by Amgen Europe B.V. to reduce the risk of neutropenia, febrile neutropenia, and chemotherapy-induce…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
A clinical trial is recruiting to evaluate the efficacy of empirical anti-infective therapy in patients with febrile neutropenia.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies [Phase 4]
Phase 4 trial comparing ciprofloxacin to ceftazidime as empirical therapy for high-risk febrile neutropenia in children with hematologic can…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy [NA]
A completed clinical trial evaluating lactoferrin for preventing febrile neutropenia and sepsis in oncohematologic children receiving induct…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Next-Generation-Sequencing Approach to Neutropenic Sepsis
A recruiting clinical trial evaluating a next-generation sequencing approach for neutropenic sepsis in patients with febrile neutropenia.
-
EMA withdrawal · 2025-06-04EMA Application withdrawn: Pelgraz Paediatric (pegfilgrastim) — Accord Healthcare S.L.U.
The EMA has withdrawn the application for Pelgraz Paediatric (pegfilgrastim) submitted by Accord Healthcare S.L.U., in the therapeutic areas…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia [Phase 4]
This Phase 4 clinical trial compares adding G-CSF to antibiotics versus antibiotics alone for resolving febrile neutropenia; the study statu…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma [NA]
This clinical trial investigates acupuncture as an add-on to G-CSF for reducing febrile neutropenia-related hospitalizations in patients wit…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens [Phase 4]
Phase 4 clinical trial comparing ceftolozane/tazobactam to meropenem for febrile neutropenia in patients colonized with or at risk for ESBL-…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer [NA]
This clinical trial evaluating early cessation of empiric antibiotics in pediatric cancer patients with febrile neutropenia was completed.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Fever Management in Children With Febrile Neutropenia [NA]
This entry indicates that a clinical trial on fever management in children with febrile neutropenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile Neutropenia
This clinical trial update assesses the BioFire FilmArray BCID2 panel for rapid detection of bloodstream infection in patients with hematolo…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN) [NA]
The CluPPFeN clinical trial investigating clusterin and PTX3 in pediatric febrile neutropenia has completed.